ATE503763T1 - Aufreinigung von faktor viii unter verwendung eines mixed-mode oder multimodalen harzes - Google Patents
Aufreinigung von faktor viii unter verwendung eines mixed-mode oder multimodalen harzesInfo
- Publication number
- ATE503763T1 ATE503763T1 AT08786090T AT08786090T ATE503763T1 AT E503763 T1 ATE503763 T1 AT E503763T1 AT 08786090 T AT08786090 T AT 08786090T AT 08786090 T AT08786090 T AT 08786090T AT E503763 T1 ATE503763 T1 AT E503763T1
- Authority
- AT
- Austria
- Prior art keywords
- purification
- factor viii
- mixed
- mode
- multimodal resin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07112287 | 2007-07-11 | ||
| PCT/EP2008/059094 WO2009007451A1 (en) | 2007-07-11 | 2008-07-11 | Purification of factor viii using a mixed-mode or multimodal resin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE503763T1 true ATE503763T1 (de) | 2011-04-15 |
Family
ID=38472947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08786090T ATE503763T1 (de) | 2007-07-11 | 2008-07-11 | Aufreinigung von faktor viii unter verwendung eines mixed-mode oder multimodalen harzes |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8399620B2 (de) |
| EP (1) | EP2167526B1 (de) |
| JP (1) | JP5323072B2 (de) |
| KR (1) | KR101293504B1 (de) |
| CN (1) | CN101730707B (de) |
| AT (1) | ATE503763T1 (de) |
| AU (1) | AU2008274195B2 (de) |
| BR (1) | BRPI0814220B8 (de) |
| CA (1) | CA2692814A1 (de) |
| DE (1) | DE602008005885D1 (de) |
| ES (1) | ES2364118T3 (de) |
| NL (1) | NL300663I2 (de) |
| PL (1) | PL2167526T3 (de) |
| RU (1) | RU2493163C2 (de) |
| WO (1) | WO2009007451A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2391613T3 (es) * | 2008-06-24 | 2012-11-28 | Octapharma Ag | Un procedimiento para purificar el factor de coagulación VIII |
| JP2012500250A (ja) | 2008-08-21 | 2012-01-05 | オクタファルマ アクチェン ゲゼルシャフト | 組換えにより産生したヒト第ｖｉｉｉ及び第ｉｘ因子 |
| US8945895B2 (en) | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| US8277649B2 (en) | 2009-12-14 | 2012-10-02 | General Electric Company | Membranes and associated methods for purification of antibodies |
| PL2538968T3 (pl) | 2010-02-24 | 2018-04-30 | Chiesi Farmaceutici S.P.A. | Sposób wytwarzania i oczyszczania rekombinowanej lizosomalnej alfamannozydazy |
| AU2011234521B2 (en) | 2010-03-30 | 2015-04-23 | Octapharma Ag | A process for purifying Vitamin K dependent proteins such as coagulation factor IX |
| ES2670827T3 (es) | 2010-03-30 | 2018-06-01 | Octapharma Ag | Proceso para la purificación del factor estimulador de colonias de granulocitos, G-CSF |
| US9422329B2 (en) | 2010-11-05 | 2016-08-23 | Hoffmann-La Roche Inc. | Optimized method for antibody capturing by mixed mode chromatography |
| SG191186A1 (en) | 2010-12-15 | 2013-07-31 | Baxter Int | Eluate collection using conductivity gradient |
| WO2013075740A1 (en) | 2011-11-23 | 2013-05-30 | Sanofi | Antibody purification method |
| US20150275195A1 (en) | 2012-10-24 | 2015-10-01 | Genzyme Corporation | Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers |
| US20140154233A1 (en) | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
| US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
| CN103396494B (zh) * | 2013-04-27 | 2015-04-01 | 江苏省疾病预防控制中心 | 一种凝血因子ix的单克隆抗体 |
| JP6463734B2 (ja) * | 2013-05-06 | 2019-02-06 | サノフイＳａｎｏｆｉ | 抗体を精製するための連続的多工程法 |
| SG11201610431WA (en) * | 2014-06-25 | 2017-01-27 | Jhl Biotech Inc | Methods and reagents for purification of proteins |
| KR102192494B1 (ko) | 2014-08-04 | 2020-12-18 | 시에스엘 리미티드 | 인자 viii 제형 |
| SG11201706659WA (en) | 2015-03-06 | 2017-09-28 | Csl Behring Recombinant Facility Ag | Modified von willebrand factor having improved half-life |
| GB201506113D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| GB201506117D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| EP3205665A1 (de) * | 2016-02-11 | 2017-08-16 | Octapharma AG | Verfahren zur trennung von faktor viii aus blutprodukten |
| GB201617240D0 (en) * | 2016-10-11 | 2016-11-23 | Profactor Pharma Ltd | Purification process |
| KR20220029733A (ko) | 2019-07-04 | 2022-03-08 | 체에스엘 베링 렝나우 아게 | 응고 인자 viii의 시험관내 안정성을 증가시키기 위한 절단된 폰 빌레브란트 인자 (vwf) |
| EP4058049A1 (de) | 2019-11-11 | 2022-09-21 | CSL Behring Lengnau AG | Polypeptide zur induktion der toleranz gegen faktor viii |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302006D0 (sv) * | 1992-10-02 | 1993-06-11 | Kabi Pharmacia Ab | Protein formulation |
| SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
| SE503424C2 (sv) * | 1994-11-14 | 1996-06-10 | Pharmacia Ab | Process för rening av rekombinant koagulationsfaktor VIII |
| IL157309A0 (en) * | 2003-08-07 | 2004-02-19 | Applied Research Systems | Method for the purification of a non-immunoglobulin protein |
| BRPI0519626A2 (pt) | 2004-12-23 | 2009-02-25 | Novo Nordisk Healthcare Ag | mÉtodos para a reduÇço do teor de um ou mais contaminantes, do teor de proteÍna s em uma composiÇço, do teor de um ou mais contaminantes de proteÍna em um sobrenadante de cultura de cÉlula, do teor de proteÍna s em um sobrenadante de cultura de cÉlula, composiÇço compreendendo uma proteÍna dependente de vitamina k de interesse |
| EP1707634A1 (de) | 2005-03-29 | 2006-10-04 | Octapharma AG | Verfahren zur Isolierung von rekombinant hergestellten Proteinen |
| ES2391613T3 (es) | 2008-06-24 | 2012-11-28 | Octapharma Ag | Un procedimiento para purificar el factor de coagulación VIII |
-
2008
- 2008-07-11 JP JP2010515524A patent/JP5323072B2/ja active Active
- 2008-07-11 US US12/668,530 patent/US8399620B2/en active Active
- 2008-07-11 BR BRPI0814220A patent/BRPI0814220B8/pt not_active IP Right Cessation
- 2008-07-11 AU AU2008274195A patent/AU2008274195B2/en not_active Ceased
- 2008-07-11 EP EP08786090A patent/EP2167526B1/de active Active
- 2008-07-11 RU RU2010103528/10A patent/RU2493163C2/ru active
- 2008-07-11 CN CN200880023645.XA patent/CN101730707B/zh active Active
- 2008-07-11 WO PCT/EP2008/059094 patent/WO2009007451A1/en active Application Filing
- 2008-07-11 AT AT08786090T patent/ATE503763T1/de not_active IP Right Cessation
- 2008-07-11 CA CA 2692814 patent/CA2692814A1/en not_active Abandoned
- 2008-07-11 PL PL08786090T patent/PL2167526T3/pl unknown
- 2008-07-11 DE DE602008005885T patent/DE602008005885D1/de active Active
- 2008-07-11 ES ES08786090T patent/ES2364118T3/es active Active
- 2008-07-11 KR KR1020107001510A patent/KR101293504B1/ko active IP Right Grant
-
2014
- 2014-04-15 NL NL300663C patent/NL300663I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101730707A (zh) | 2010-06-09 |
| EP2167526B1 (de) | 2011-03-30 |
| PL2167526T3 (pl) | 2011-09-30 |
| EP2167526A1 (de) | 2010-03-31 |
| US8399620B2 (en) | 2013-03-19 |
| CA2692814A1 (en) | 2009-01-15 |
| US20100204452A1 (en) | 2010-08-12 |
| DE602008005885D1 (de) | 2011-05-12 |
| JP2010533150A (ja) | 2010-10-21 |
| AU2008274195B2 (en) | 2013-09-05 |
| NL300663I2 (de) | 2016-09-22 |
| BRPI0814220B1 (pt) | 2019-09-17 |
| ES2364118T9 (es) | 2014-05-19 |
| WO2009007451A1 (en) | 2009-01-15 |
| CN101730707B (zh) | 2014-12-17 |
| KR20100051620A (ko) | 2010-05-17 |
| JP5323072B2 (ja) | 2013-10-23 |
| BRPI0814220B8 (pt) | 2021-05-25 |
| KR101293504B1 (ko) | 2013-08-07 |
| BRPI0814220A2 (pt) | 2015-01-06 |
| ES2364118T3 (es) | 2011-08-25 |
| RU2493163C2 (ru) | 2013-09-20 |
| RU2010103528A (ru) | 2011-08-20 |
| AU2008274195A1 (en) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE503763T1 (de) | Aufreinigung von faktor viii unter verwendung eines mixed-mode oder multimodalen harzes | |
| WO2020102741A8 (en) | Methods and compositions for protein sequencing | |
| DE602005020743D1 (de) | Verfahren zur behandlung von osteoarthritis mit anti-il-6 antikörpern | |
| MX2016011934A (es) | Inmunoglobulina hibrida conteniendo un enlace no-peptidilico. | |
| MX2020003798A (es) | Metodos para la purificacion de arilsulfatasa a. | |
| EA200970231A1 (ru) | СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ | |
| MY162624A (en) | Antibodies directed to her-3 and uses thereof | |
| IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
| MX2021011726A (es) | Escindasas modificadas, usos de las mismas y kits relacionados. | |
| MX2020010806A (es) | Peptidos anti-inflamatorios y usos de los mismos. | |
| ATE502650T1 (de) | Verfahren zur befestigung von effektor-molekülen an proteinen | |
| UA106458C2 (uk) | Чутливий до сульфонілсечовини репресорний білок | |
| NZ781143A (en) | Anti-vegf protein compositions and methods for producing the same | |
| DE10390418D2 (de) | Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen | |
| WO2010002160A3 (ko) | 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도 | |
| DE502004007067D1 (de) | Verfahren zur herstellung zyklischer moleküle | |
| DE602006010990D1 (de) | Verfahren zur dipeptidherstellung | |
| MX2018003445A (es) | Expresion de proteinas que contienen fc. | |
| ATE503003T1 (de) | Verfahren zur herstellung rekombinanter polypeptide | |
| DE60327228D1 (de) | Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davon | |
| DE502006004542D1 (de) | Verfahren zur charakterisierung der glycosilierung | |
| ZA202304030B (en) | Modified cxcl10 for immunotherapy of cancer diseases | |
| EP3956347A4 (de) | Chimäre daf-mcp-proteine, verfahren zu deren herstellung und verwendung des chimären proteins zur behandlung pathologischer zustände in zusammenhang mit dem komplementsystem | |
| WO2018164507A3 (ko) | Mast4 유전자를 이용한 세포외 기질 생산용 조성물 및 그 제조방법 | |
| IN2013MU01384A (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |